Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Nicholson

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
BMJ (Clinical Research Ed.)|September 30, 1989
Failure of interferon alfa and tribavirin in rabies encephalitisM J Warrell, N J White, S Looareesuwan, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findingsB Killingley, J Greatorex, S Cauchemez, et al.
The New England Journal of Medicine|September 26, 1997
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study GroupF G Hayden, A D Osterhaus, J J Treanor, et al.
Lancet (London, England)|August 6, 1983
An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxisM J Warrell, D A Warrell, P Suntharasamai, et al.
Journal of Biological Standardization|April 1, 1979
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactionsK G Nicholson, D A Tyrrell, P Harrison, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apartK G Nicholson, K R Abrams, S Batham, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancyR L Puleston, G Bugg, K Hoschler, et al.
Thorax|July 15, 2010
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)J S Nguyen-Van-Tam, P J M Openshaw, A Hashim, et al.
Lancet (London, England)|July 4, 1998
Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthmaK G Nicholson, J S Nguyen-Van-Tam, A H Ahmed, et al.
Epidemiology and Infection|August 2, 2014
Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UKG A Nyland, B C McKenzie, P R Myles, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
BMJ (Clinical Research Ed.)|September 30, 1989
Failure of interferon alfa and tribavirin in rabies encephalitisM J Warrell, N J White, S Looareesuwan, et al.
Health Technology Assessment (Winchester, England)|October 7, 2010
Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findingsB Killingley, J Greatorex, S Cauchemez, et al.
The New England Journal of Medicine|September 26, 1997
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study GroupF G Hayden, A D Osterhaus, J J Treanor, et al.
Lancet (London, England)|August 6, 1983
An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxisM J Warrell, D A Warrell, P Suntharasamai, et al.
Journal of Biological Standardization|April 1, 1979
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactionsK G Nicholson, D A Tyrrell, P Harrison, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apartK G Nicholson, K R Abrams, S Batham, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancyR L Puleston, G Bugg, K Hoschler, et al.
Thorax|July 15, 2010
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)J S Nguyen-Van-Tam, P J M Openshaw, A Hashim, et al.
Lancet (London, England)|July 4, 1998
Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthmaK G Nicholson, J S Nguyen-Van-Tam, A H Ahmed, et al.
Epidemiology and Infection|August 2, 2014
Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UKG A Nyland, B C McKenzie, P R Myles, et al.
Pageof 11